Recombinant Anti-MARV GP Antibody (V3S-1022-YC4089) (CAT#: V3S-1022-YC4089)

Send Inquiry
  • fig1
    Figure 1 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in Western Blot.
  • fig1
    Figure 2 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in ELISA.
  • fig1
    Figure 3 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in Dot Blot.

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a recombinant Mouse antibody provided by CreativeBiolabs. The antibody is specific for MAvian reovirus GP. It can be used for MARV GP detection in Western Blot (WB), Immunoprecipitation (IP). It was expressed in mammalian cells (293F or CHO) with antibody encoding genes and purified by affinity chromatography. Each lot of this antibody is quality control tested by SDS-PAGE and SEC-HPLC analysis. For highly sensitive assays, we recommend the ultra purified form of the product, which has a lower endotoxin limit than standard antibody, less than 1 EU/mg or even 0.1 EU/mg.
Clonality Monoclonal
Host Species Mouse
Target Species Marburg virus (MARV)
Epitope Located in the sequence: DAVTE.
Isotype IgG

Property

Expression Species HEK293F or CHO Cell line
Conjugation Unconjugated, also available for Biotin, HRP, FITC and PE-labeled form.
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Purified with Protein A or G affinity chromatography
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application WB; IP

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target MARV GP
Alternative Name GP; Envelope glycoprotein; MARV GP; Marburg virus-Musoke, Kenya, 1980
Gene ID 920945
UniProt P35253
Research Area Microbiology

Tested Data

WB

Figure 1 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in Western Blot.

Western blot analysis of V3S-1022-YC4089 was performed by loading recombinant lake victoria marburgvirus envelope glycoprotein (GP).

V3S-1022-YC4089 incubation concentration: 2ng/μL.

Lane 1: Reduced antigen (0.1 μg)
Lane 2: Reduced antigen (0.3 μg)
Lane 3: Reduced antigen (0.6 μg)

Figure 1 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in Western Blot.

ELISA

Figure 2 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in ELISA.

ELISA analysis of V3S-1022-YC4089 was performed by coating with recombinant lake victoria marburgvirus envelope glycoprotein (GP).

Figure 2 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in ELISA.

DB

Figure 3 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in Dot Blot.

Dot blot analysis of V3S-1022-YC4089 was performed by coating with recombinant lake victoria marburgvirus envelope glycoprotein (GP).

V3S-1022-YC4089 incubation concentration: 2 ng/μL.

Figure 3 Anti-MARV GP Recombinant Antibody (V3S-1022-YC4089) in Dot Blot.

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry